Custom crystal tombstone commemorating clinical trial financing provided for biopharmaceutical company, Clovis Oncology. The clinical trial sponsored by Clovis involves an ovarian cancer study.
(9ALJ233)
Custom crystal tombstone commemorating clinical trial financing provided for biopharmaceutical company, Clovis Oncology. The clinical trial sponsored by Clovis involves an ovarian cancer study.
(9ALJ233)Custom Lucite, with an embedded champagne cork, celebrating the approval by the Food and Drug Administration (FDA) of the obesity treatment Plenity. Plenity was developed by Boston-based biotech firm Gelesis.
(9AMF149)Custom Lucite deal toy commemorating the acquisition of San Diego-based Ultimate Labs, a testing laboratory for the pharmaceutical, biotechnology, medical device, and food industries.
(9ALJ145)Custom crystal award featuring a 3-D etch of a DNA strand.
(9ACJ007)Custom Lucite tombstone commemorating equity financing for Georgetown, Texas-based biotech firm DisperSol Technologies.
(9ACJ018)Custom crystal tombstone celebrating a second close of Series A financing for Fusion Pharmaceuticals. The Hamilton, Ontario-based firm is focused on radiotherapeutics for treating cancer.
(8ALJ479)Custom crystal tombstone marking a private placement by Swiss biopharmaceutical company Auris Medical. Ladenburg Thalmann acted as exclusive placement agent.
(8AMF064)Custom crystal commemorating a research collaboration involving Neurocrine Biosciences and Jnana Therapeutics. The research centers on finding new small-molecule therapeutics targeting central nervous system disorders.
(8ALJ498)Custom crystal deal toy commemorating a follow-on offering by EnteroMedics. Ladenburg Thalmann acted as sole bookrunning manager for the follow-on issue by the medical device developer. Based in St. Paul, Minnesota, the company was renamed ReShape Lifesciences in October 2017.
(7AMF287)
